Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

R2 Studio Q/RCT820

K-Number: K222219 · 2022-12-06

Decision Date2022-12-06
Product CodeOAS
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

R2 Studio Q/RCT820 is a medical device manufactured by Megagen Implant Co., Ltd.. It received FDA 510(k) clearance on 2022-12-06 under approval number K222219. The device is classified under product code OAS. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the R2 Studio Q/RCT820?

R2 Studio Q/RCT820 is a medical device that received FDA 510(k) clearance on 2022-12-06. It is manufactured by Megagen Implant Co., Ltd.. The 510(k) number is K222219.

When was R2 Studio Q/RCT820 approved by the FDA?

R2 Studio Q/RCT820 received FDA 510(k) clearance on 2022-12-06, under approval number K222219.

What company makes R2 Studio Q/RCT820?

R2 Studio Q/RCT820 is manufactured by Megagen Implant Co., Ltd..

What is the FDA product code for R2 Studio Q/RCT820?

The FDA product code for R2 Studio Q/RCT820 is OAS.

Other Devices by Megagen Implant Co., Ltd.

View all 22 devices →

Related Devices (Code: OAS)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.